Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV
- 1 December 2007
- journal article
- review article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 15 (24) , 7576-7580
- https://doi.org/10.1016/j.bmc.2007.09.010
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- A Novel Bis-Tetrahydrofuranylurethane-Containing Nonpeptidic Protease Inhibitor (PI), GRL-98065, Is Potent against Multiple-PI-Resistant Human Immunodeficiency Virus In VitroAntimicrobial Agents and Chemotherapy, 2007
- Ultra-high Resolution Crystal Structure of HIV-1 Protease Mutant Reveals Two Binding Sites for Clinical Inhibitor TMC114Journal of Molecular Biology, 2006
- Synthesis and antiviral activities of novel N-alkoxy-arylsulfonamide-based HIV protease inhibitorsBioorganic & Medicinal Chemistry Letters, 2005
- Lysine sulfonamides as novel HIV-protease inhibitors: Nε-disubstituted ureasBioorganic & Medicinal Chemistry Letters, 2004
- Novel arylsulfonamides possessing sub-picomolar HIV protease activities and potent anti-HIV activity against wild-type and drug-resistant viral strainsBioorganic & Medicinal Chemistry Letters, 2004
- AIDS — The First 20 YearsNew England Journal of Medicine, 2001
- Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in AdultsNew England Journal of Medicine, 1999
- Evaluation of furofuran as a P2 ligand for symmetry-based HIV protease inhibitorsBioorganic & Medicinal Chemistry Letters, 1996
- Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSScience, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983